A carregar...

Hemodynamic and clinical effects of selexipag in children with pulmonary hypertension

Selexipag is an oral prostacyclin receptor agonist; it was recently approved for use in adults with pulmonary arterial hypertension. The safety and efficacy of selexipag has not yet been determined in the pediatric population. We describe short-term hemodynamic and clinical data with selexipag thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Abraham Rothman, Gabriel Cruz, William N. Evans, Humberto Restrepo
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2020-02-01
Colecção:Pulmonary Circulation
Acesso em linha:https://doi.org/10.1177/2045894019876545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!